International Business Machines Corporation (BVMF:IBMB34)

Intercept Pharmaceuticals Statistics

Total Valuation

BVMF:IBMB34 has a market cap or net worth of BRL 1.29 trillion. The enterprise value is 1.58 trillion.

Market Cap	1.29T
Enterprise Value	1.58T

Important Dates

The last earnings date was Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.49%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	929.51M

Valuation Ratios

The trailing PE ratio is 40.68 and the forward PE ratio is 21.18.

PE Ratio	40.68
Forward PE	21.18
PS Ratio	3.71
PB Ratio	8.60
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.40, with an EV/FCF ratio of 23.75.

EV / Earnings	49.82
EV / Sales	4.45
EV / EBITDA	18.40
EV / EBIT	26.23
EV / FCF	23.75

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 2.45.

Current Ratio	0.91
Quick Ratio	0.76
Debt / Equity	2.45
Debt / EBITDA	4.37
Debt / FCF	5.53
Interest Coverage	5.98

Financial Efficiency

Return on equity (ROE) is 22.67% and return on invested capital (ROIC) is 7.58%.

Return on Equity (ROE)	22.67%
Return on Assets (ROA)	4.81%
Return on Invested Capital (ROIC)	7.58%
Return on Capital Employed (ROCE)	9.81%
Revenue Per Employee	1.29M
Profits Per Employee	117,584
Employee Count	270,300
Asset Turnover	0.45
Inventory Turnover	21.57

Taxes

In the past 12 months, BVMF:IBMB34 has paid 2.18 billion in taxes.

Income Tax	2.18B
Effective Tax Rate	6.41%

Stock Price Statistics

The stock price has increased by +31.26% in the last 52 weeks. The beta is 0.68, so BVMF:IBMB34's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	+31.26%
50-Day Moving Average	1,537.24
200-Day Moving Average	1,418.22
Relative Strength Index (RSI)	27.44
Average Volume (20 Days)	65

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.26

Income Statement

In the last 12 months, BVMF:IBMB34 had revenue of BRL 348.94 billion and earned 31.78 billion in profits. Earnings per share was 33.67.

Revenue	348.94B
Gross Profit	200.89B
Operating Income	59.25B
Pretax Income	34.10B
Net Income	31.78B
EBITDA	77.28B
EBIT	59.25B
Earnings Per Share (EPS)	33.67

Balance Sheet

The company has 84.17 billion in cash and 368.99 billion in debt, giving a net cash position of -284.82 billion.

Cash & Cash Equivalents	84.17B
Total Debt	368.99B
Net Cash	-284.82B
Net Cash Per Share	n/a
Equity (Book Value)	150.32B
Book Value Per Share	160.91
Working Capital	-18.92B

Cash Flow

In the last 12 months, operating cash flow was 72.37 billion and capital expenditures -5.68 billion, giving a free cash flow of 66.69 billion.

Operating Cash Flow	72.37B
Capital Expenditures	-5.68B
Free Cash Flow	66.69B
FCF Per Share	n/a

Margins

Gross margin is 57.57%, with operating and profit margins of 16.98% and 9.11%.

Gross Margin	57.57%
Operating Margin	16.98%
Pretax Margin	9.77%
Profit Margin	9.11%
EBITDA Margin	22.15%
EBIT Margin	16.98%
FCF Margin	19.11%

Dividends & Yields

This stock pays an annual dividend of 25.42, which amounts to a dividend yield of 1.77%.

Dividend Per Share	25.42
Dividend Yield	1.77%
Dividend Growth (YoY)	14.45%
Years of Dividend Growth	1
Payout Ratio	106.31%
Buyback Yield	-1.49%
Shareholder Yield	0.28%
Earnings Yield	2.46%
FCF Yield	5.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:IBMB34 has an Altman Z-Score of 3.12 and a Piotroski F-Score of 5.

Altman Z-Score	3.12
Piotroski F-Score	5